The effect of photodynamic therapy using Radachlorin on biofilm-forming multidrug-resistant bacteria

다국어 초록 (Multilingual Abstract)

Objectives: This study aimed to test the effect of photodynamic therapy (PDT) on the inhibition and removal of biofilms containing multidrug-resistant Acinetobacter baumannii.Methods: Using multidrug-resistant A. baumannii strains, an antibiotic susceptibility test was performed using the Gram-negative identification card of the Vitek 2 system (bioMérieux Inc., France), as well as an analysis of resistance genes, the effects of treatment with a light-emitting diode (LED) array using Radachlorin (RADA-PHARMA Co., Ltd., Russia), and transmission and scanning electron microscopy to confirm the biofilm-inhibitory effect of PDT.Results: The antibiotic susceptibility test revealed multiple resistance to the antibiotics imipenem and meropenem in the carbapenem class. A class-D–type β-lactamase was found, and OXA-23 and OXA-51 were found in 100% of 15 A. baumannii strains. After PDT using Radachlorin, morphological observations revealed an abnormal structure due to the loss of the cell membrane and extensive morphological changes, including low intracellular visibility and small vacuoles attached to the cell membrane.Conclusion: PDT involving a combination of LED and Radachlorin significantly eliminated the biofilm of multidrug-resistant A. baumannii. Observations made using electron microscopy showed that PDT combining LED and Radachlorin was effective. Additional studies on the effective elimination of biofilms containing multidrug-resistant bacteria are necessary, and we hope that a treatment method superior to sterilization with antibiotics will be developed in the future.

참고문헌 (Reference)

1 Lee K, "Wide dissemination of OXA-type carbapenemases in clinical Acinetobacter spp. isolates from South Korea" 33 : 520-524, 2009

2 Foote CS, "Type ℃ and type ℃ mechanisms of photodynamic action" 339 : 22-38, 1987

3 Kim CK, "Prevalence and diversity of carbapenemases among imipenem-nonsusceptible Acinetobacter isolates in Korea : emergence of a novel OXA-182" 68 : 432-438, 2010

4 Chong Y, "Present situation of antimicrobial resistance in Korea" 6 : 189-195, 2000

5 Ochsner M, "Photophysical and photobiological processes in the photodynamic therapy of tumours" 39 : 1-18, 1997

6 Wilson M, "Photolysis of oral bacteria and its potential use in the treatment of caries and periodontal disease" 75 : 299-306, 1993

7 Dai T, "Photodynamic therapy for Acinetobacter baumannii burn infections in mice" 53 : 3929-3934, 2009

8 Uzdensky AB, "Photodynamic effect of novel chlorin e6 derivatives on a single nerve cell" 74 : 2185-2197, 2004

9 정석훈 ; 배일권 ; Kwang Ok Park ; Young Jun An ; Seung Ghyu Sohn ; Seon Ju Jang ; Ki Suk Yang ; 용동은 ; 성광훈 ; 이경원 ; 이상희, "Outbreaks of Imipenem-Resistant Acinetobacter baumannii Producing Carbapenemases in Korea" 한국미생물학회 44 (44): 423-431, 2006

10 Emerson RJ 4th, "Nanoscale investigation of pathogenic microbial adhesion to a biomaterial" 70 : 6012-6022, 2004

11 Woodford N, "Multiplex PCR for genes encoding prevalent OXA carbapenemases in Acinetobacter spp" 27 : 351-353, 2006

12 Jeong SH, "Monitoring of antimicrobial resistance on general hospitals in Korea. Academic research report final results" Korea Centers for Disease Control and Prevention 2011

13 Murray PR, "Manual of clinical microbiology" American Society for Microbiology 1999

14 Jeon BC, "Investigation of a nosocomial outbreak of imipenem-resistant Acinetobacter baumannii producing the OXA-23 beta-lactamase in korea" 43 : 2241-2245, 2005

15 Crump JA, "Intravascular catheter-associated infections" 19 : 1-8, 2000

16 Aubert G, "In-vitro activity of cephalosporins alone and combined with sulbactam against various strains of Acinetobacter baumannii with different antibiotic resistance profiles" 37 : 155-160, 1996

17 Ko KS, "High rates of resistance to colistin and polymyxin B in subgroups of Acinetobacter baumannii isolates from Korea" 60 : 1163-1167, 2007

18 Ren D, "Gene expression in Escherichia coli biofilms" 64 : 515-524, 2004

19 Bradford PA., "Extended-spectrum beta-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat" 14 : 933-951, 2001

20 Segal H, "Extended-10 promoter in ISAba-1 upstream of blaOXA-23 from Acinetobacter baumannii" 51 : 3040-3041, 2007

21 Gales AC, "Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients : geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program(1997-1999)" 32 (32): S104-S113, 2001

22 Corbella X, "Emergence and rapid spread of carbapenem resistance during a large and sustained hospital outbreak of multiresistant Acinetobacter baumannii" 38 : 4086-4095, 2000

23 Privalov VA, "Clinical trials of a new chlorin photosensitizer for photodynamic therapy of malignant tumors" International Symposium on Biomedical Optics 178-189, 2002

24 Queenan AM, "Carbapenemases : the versatile beta-lactamases" 20 : 440-458, 2007

25 Lee HW, "Capacity of multidrug-resistant clinical isolates of Acinetobacter baumannii to form biofilm and adhere to epithelial cell surfaces" 14 : 49-54, 2008

26 Donlan RM, "Biofilms : survival mechanisms of clinically relevant microorganisms" 15 : 167-193, 2002

27 Wong TW, "Bactericidal effects of toluidine blue-mediated photodynamic action on Vibrio vulnificus" 49 : 895-902, 2005

28 Otto M., "Bacterial biofilms" Springer 207-228, 2008

29 Dunne WM Jr, "Bacterial adhesion : seen any good biofilms lately?" 15 : 155-166, 2002

30 Bergogne-Berezin E, "Acinetobacter spp. as nosocomial pathogens: microbiological, clinical, and epidemiological features" 9 : 148-165, 1996

31 홍성극 ; 성문우 ; 이도훈 ; 김의종, "2006년부터 2010년까지 한 병원의 집중치료실에서 분리된 Imipenem 내성 Acinetobacter baumannii의 비율과 Carbapenem 계열 항균제 처방의 상관관계" 대한진단검사의학회 2 (2): 232-234, 2012